2KTZ
Inhibitor Induced Structural Change in the HCV IRES Domain IIa RNA
Summary for 2KTZ
| Entry DOI | 10.2210/pdb2ktz/pdb |
| Related | 2KU0 |
| Descriptor | HCV IRES Domain IIa RNA, (7R)-7-[(dimethylamino)methyl]-1-[3-(dimethylamino)propyl]-7,8-dihydro-1H-furo[3,2-e]benzimidazol-2-amine (2 entities in total) |
| Functional Keywords | hepatitis c virus, rna structure, antiviral, rna |
| Biological source | Hepatitis C virus (HCV) |
| Total number of polymer chains | 1 |
| Total formula weight | 12439.60 |
| Authors | Paulsen, R.B.,Seth, P.P.,Swayze, E.E.,Griffey, R.H.,Skalicky, J.J.,Cheatham III, T.E.,Davis, D.R. (deposition date: 2010-02-10, release date: 2010-04-28, Last modification date: 2024-05-22) |
| Primary citation | Paulsen, R.B.,Seth, P.P.,Swayze, E.E.,Griffey, R.H.,Skalicky, J.J.,Cheatham, T.E.,Davis, D.R. Inhibitor-induced structural change in the HCV IRES domain IIa RNA. Proc.Natl.Acad.Sci.USA, 107:7263-7268, 2010 Cited by PubMed Abstract: Translation of the hepatitis C virus (HCV) RNA is initiated from a highly structured internal ribosomal entry site (IRES) in the 5' untranslated region (5' UTR) of the RNA genome. An important structural feature of the native RNA is an approximately 90 degrees helical bend localized to domain IIa that positions the apical loop of domain IIb of the IRES near the 40S ribosomal E-site to promote eIF2-GDP release, facilitating 80S ribosome assembly. We report here the NMR structure of a domain IIa construct in complex with a potent small-molecule inhibitor of HCV replication. Molecular dynamics refinement in explicit solvent and subsequent energetic analysis indicated that each inhibitor stereoisomer bound with comparable affinity and in an equivalent binding mode. The in silico analysis was substantiated by fluorescence-based assays showing that the relative binding free energies differed by only 0.7 kcal/mol. Binding of the inhibitor displaces key nucleotide residues within the bulge region, effecting a major conformational change that eliminates the bent RNA helical trajectory, providing a mechanism for the antiviral activity of this inhibitor class. PubMed: 20360559DOI: 10.1073/pnas.0911896107 PDB entries with the same primary citation |
| Experimental method | SOLUTION NMR |
Structure validation
Download full validation report
